CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: Shlomchik and colleagues demonstrated antigen-specific memory T cell (TM)-mediated GVL against chronic phase and blast crisis chronic myeloid leukemia (CML) when they transferred CD8+ TM from murine donors vaccinated against the H60 minor H antigen (61).